BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24129764)

  • 1. CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.
    Kühnöl C; Herbarth M; Föll J; Staege MS; Kramm C
    Cancer Immunol Immunother; 2013 Dec; 62(12):1797-809. PubMed ID: 24129764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of p38 mitogen-activated protein kinase inhibition on immunostimulatory properties of human 6-sulfo LacNAc dendritic cells.
    Langosch S; Wehner R; Malecka A; Franks HA; Schäkel K; Bachmann M; Jackson AM; Schmitz M
    Immunobiology; 2016 Feb; 221(2):166-74. PubMed ID: 26391152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhizoctonia bataticola lectin (RBL) induces mitogenesis and cytokine production in human PBMC via p38 MAPK and STAT-5 signaling pathways.
    Pujari R; Nagre NN; Chachadi VB; Inamdar SR; Swamy BM; Shastry P
    Biochim Biophys Acta; 2010 Dec; 1800(12):1268-75. PubMed ID: 20870009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway.
    Peng H; Wang X; Barnes PF; Tang H; Townsend JC; Samten B
    J Biol Chem; 2011 Jul; 286(27):24508-18. PubMed ID: 21586573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.
    Jacobs JF; Punt CJ; Lesterhuis WJ; Sutmuller RP; Brouwer HM; Scharenborg NM; Klasen IS; Hilbrands LB; Figdor CG; de Vries IJ; Adema GJ
    Clin Cancer Res; 2010 Oct; 16(20):5067-78. PubMed ID: 20736326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers.
    Arrighi JF; Rebsamen M; Rousset F; Kindler V; Hauser C
    J Immunol; 2001 Mar; 166(6):3837-45. PubMed ID: 11238627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
    Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
    Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.
    Mitchell DA; Cui X; Schmittling RJ; Sanchez-Perez L; Snyder DJ; Congdon KL; Archer GE; Desjardins A; Friedman AH; Friedman HS; Herndon JE; McLendon RE; Reardon DA; Vredenburgh JJ; Bigner DD; Sampson JH
    Blood; 2011 Sep; 118(11):3003-12. PubMed ID: 21768296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
    Sampson JH; Schmittling RJ; Archer GE; Congdon KL; Nair SK; Reap EA; Desjardins A; Friedman AH; Friedman HS; Herndon JE; Coan A; McLendon RE; Reardon DA; Vredenburgh JJ; Bigner DD; Mitchell DA
    PLoS One; 2012; 7(2):e31046. PubMed ID: 22383993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin-2 receptor α chain (CD25) plays an important role in regulating monocyte-derived CD40 expression during anti-porcine cellular responses.
    Sun ZG; Wang Z; Zhu LM; Fang YS; Yu LZ; Xu H
    Transplant Proc; 2012 May; 44(4):1139-42. PubMed ID: 22564647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.
    Srivastava RM; Trivedi S; Concha-Benavente F; Gibson SP; Reeder C; Ferrone S; Ferris RL
    Clin Cancer Res; 2017 Feb; 23(3):707-716. PubMed ID: 27496866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
    Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.
    Müller I; Altherr D; Eyrich M; Flesch B; Friedmann KS; Ketter R; Oertel J; Schwarz EC; Technau A; Urbschat S; Eichler H
    Cytotherapy; 2016 Sep; 18(9):1146-61. PubMed ID: 27424145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas.
    Kühnöl CD; Staege MS; Kramm CM
    Anticancer Agents Med Chem; 2016; 16(11):1468-1473. PubMed ID: 26891975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells.
    Stephenson RM; Lim CM; Matthews M; Dietsch G; Hershberg R; Ferris RL
    Cancer Immunol Immunother; 2013 Aug; 62(8):1347-57. PubMed ID: 23685782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophages.
    Marriott JB; Clarke IA; Dalgleish AG
    Clin Exp Immunol; 2001 Jul; 125(1):64-70. PubMed ID: 11472427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific immunotherapy enhances CD8
    Tsai YG; Yang KD; Wen YS; Hung CH; Chien JW; Lin CY
    Pediatr Allergy Immunol; 2019 Aug; 30(5):531-539. PubMed ID: 30968455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective induction of p38 mitogen-activated protein kinase activity following A6H co-stimulation in primary human CD4(+) T cells.
    Labuda T; Sundstedt A; Dohlsten M
    Int Immunol; 2000 Mar; 12(3):253-61. PubMed ID: 10700460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.